戻る Agenda
Session 5
Session Chair(s)
Takayuki Hanashima
Study Leader, Study Leadership Japan
Novartis Pharma K.K., Japan
Masashi Uchida
Senior Manager, Clinical Trial Monitoring Group
Bristol-Myers Squibb K.K., Japan
Kaori Watanabe, MPharm
CRC, Clinical Research Promotion Center
The University of Tokyo Hospital, Japan
Speaker(s)
Presentation5-1
Masahiro Wanikawa
Chugai Pharmaceutical Co. Ltd., Japan
Oncology Clinical Development Dept.
Presentation5-2
Hideto Minohara
University of Tsukuba Hospital, Japan
T-CReDO
Presentation5-3
Natsuko Ozeki
Carepro, Inc, Japan
Director of preventive healthcare division
Takuma Matsunaga
MICIN, Inc., Japan
Business Producer, DCT Unit